Roseomonas: Difference between revisions
From IDWiki
Roseomonas
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
=== Microbiology === |
=== Microbiology === |
||
| − | * Genus of [[Stain::Gram-negative]] [[Shape::bacillus|bacilli]] or [[Shape::coccobacillus|coccobacilli]] |
+ | * Genus of slow-growing [[Stain::Gram-negative]] [[Shape::bacillus|bacilli]] or [[Shape::coccobacillus|coccobacilli]] within the family [[Family::Acetobacteraceae]] |
* Previously referred to as CDC pink coccoid groups I through IV |
* Previously referred to as CDC pink coccoid groups I through IV |
||
| + | * Related to [[Methylobacterium]] |
||
* Catalase and oxidase positive |
* Catalase and oxidase positive |
||
| + | * Non-fermentative |
||
| + | * Aerobic |
||
* Pigmented, either pink or purple-pink |
* Pigmented, either pink or purple-pink |
||
| + | * Isolated from environmental samples including soil, water, and plants |
||
* Species of possible clinical importance include: |
* Species of possible clinical importance include: |
||
** [[Roseomonas gilardii]] subspecies gilardii (usually clinically important) and rosea |
** [[Roseomonas gilardii]] subspecies gilardii (usually clinically important) and rosea |
||
| ⚫ | |||
** [[Roseomonas mucosa]] |
** [[Roseomonas mucosa]] |
||
| ⚫ | |||
| + | ** ''Roseomonas'' genomospecies 4, 5, and 6 |
||
== Clinical Manifestations == |
== Clinical Manifestations == |
||
| + | * More common in patients with significant comorbidities or immunocompromise |
||
| − | * Bacteremia |
||
| + | ** Malignancy on chemotherapy (solid-organ and hematologic), particularly with neutropenia |
||
| − | * Central line infection |
||
| + | ** Also advanced HIV, CKD, and diabetes mellitus |
||
| − | * Intraabdominal abscess |
||
| + | * [[Gram-negative bacteremia|Bacteremia]] (75%), including [[central line infection]] |
||
| − | * Respiratory tract infection |
||
| + | * Musculoskeletal infections (8%), including [[osteomyelitis]] and [[septic arthritis]] |
||
| − | * Urinary tract infection |
||
| + | * [[Skin and soft tissue infection]] (6%) |
||
| + | * [[Peritoneal dialysis-associated peritonitis]] (6%) |
||
| + | * Extremely rare cases of endophthalmitis, endocarditis, pneumonia, ventriculitis, and pre-aortic abscess |
||
| + | * Often seen in polymicrobial cultures, particularly [[coagulase-negative staphylococci]], [[Micrococcus]], [[Pseudomonas]], coryneform bacteria, and many others |
||
== Management == |
== Management == |
||
| − | * Generally susceptible to [[aminoglycosides]], [[tetracycline]], and [[imipenem]] |
+ | * Generally susceptible to [[aminoglycosides]], [[tetracycline]], and [[imipenem]] |
| + | * May be susceptible to [[fluoroquinolones|fluoro]]{{DISPLAYTITLE:''Roseomonas''}}[[fluoroquinolones|quinolones]] |
||
| + | * Generally resistant to [[penicillins]] (including combinations with β-lactamase inhibitors), [[cephalosporins]], and [[co-trimoxazole]] |
||
| + | * Remove the central line if [[CLABSI]] is suspected |
||
| + | |||
| + | == Further Reading == |
||
| + | |||
| + | * ''Roseomonas'' species infections in humans: a systematic review. ''J Chemother''. 2020;32(5):226-236. doi: [https://doi.org/10.1080/1120009x.2020.1785742 10.1080/1120009X.2020.1785742] |
||
| + | |||
| + | |||
[[Category:Gram-negative bacilli]] |
[[Category:Gram-negative bacilli]] |
||
Latest revision as of 21:33, 5 July 2022
Background
Microbiology
- Genus of slow-growing Gram-negative bacilli or coccobacilli within the family Acetobacteraceae
- Previously referred to as CDC pink coccoid groups I through IV
- Related to Methylobacterium
- Catalase and oxidase positive
- Non-fermentative
- Aerobic
- Pigmented, either pink or purple-pink
- Isolated from environmental samples including soil, water, and plants
- Species of possible clinical importance include:
- Roseomonas gilardii subspecies gilardii (usually clinically important) and rosea
- Roseomonas mucosa
- Roseomonas fauriae
- Roseomonas genomospecies 4, 5, and 6
Clinical Manifestations
- More common in patients with significant comorbidities or immunocompromise
- Malignancy on chemotherapy (solid-organ and hematologic), particularly with neutropenia
- Also advanced HIV, CKD, and diabetes mellitus
- Bacteremia (75%), including central line infection
- Musculoskeletal infections (8%), including osteomyelitis and septic arthritis
- Skin and soft tissue infection (6%)
- Peritoneal dialysis-associated peritonitis (6%)
- Extremely rare cases of endophthalmitis, endocarditis, pneumonia, ventriculitis, and pre-aortic abscess
- Often seen in polymicrobial cultures, particularly coagulase-negative staphylococci, Micrococcus, Pseudomonas, coryneform bacteria, and many others
Management
- Generally susceptible to aminoglycosides, tetracycline, and imipenem
- May be susceptible to fluoroquinolones
- Generally resistant to penicillins (including combinations with β-lactamase inhibitors), cephalosporins, and co-trimoxazole
- Remove the central line if CLABSI is suspected
Further Reading
- Roseomonas species infections in humans: a systematic review. J Chemother. 2020;32(5):226-236. doi: 10.1080/1120009X.2020.1785742
